Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease

US Patent 10485811 · Granted Nov 26, 2019

Assignee

Inventors

View full patent text on Google Patents →